Self-reported use of vitamins and other nutritional supplements in adult patients with cystic fibrosis. Is daily practice in concordance with recommendations?

Abstract

A high percentage of PI patients use fat-soluble vitamins below recommendations. Therefore adequate monitoring of vitamin supplementation and status is warranted.

Adherence of Subjects With Cystic Fibrosis to Their Home Program: A Systematic Review

“…22 In another study, the percentages of the sample group who reached the recommended doses for vitamins A, D, E, and K were 9, 32, 59, and 81%, respectively. 42 One low-quality study assessed compliance with a dietitian's food guidelines. Forty-one participants (male, n ϭ 20; female, n ϭ 21) were included.…”

“…All but one study was of low quality. Four studies used participant questionnaires, 3,23,25,29 2 used parent questionnaires, 3,22 one used clinician questionnaires, 22 3 used interviews via telephone, 3,41,42 and one used pharmacy refill data and electronic recordings via MEMS SmartCap. 3 Mean adherence ranged from 22.2 Ϯ 34.2% by daily telephone diary 3 to 97.5 Ϯ 7.5% by parent questionnaire.…”

Patient-Reported Outcome Measures for Symptom Perception During a Cystic Fibrosis Exacerbation

“…Furthermore, we identified numerous measures that assessed treatment adherence in general. 13,[24][25][26][27][28][29][30][31][32][33][34][35][36][37][38] Of these, 2 studies measured adherence during an exacerbation, but they used a non-validated scale. 39,40 The Perceived Health Competence Scale, which assesses self-efficacy, 41 the Transitional Dyspnoea Index Score, 42 the Chronic Respiratory Disease Questionnaire, 43 the Pain Catastrophizing Scale, 44 the Brief Pain Inventory, 44 the Schwartz Fatigue Scale, 45 and the Quick Inventory of Depressive Symptomatology 46 were each used once during an exacerbation, but they were not developed for a CFspecific population and were therefore not included for review.…”

Медикаментозное Управление Окислительно-Восстановительным Состоянием Организма При Заболеваниях Органов Дыхания (Часть 4)

“…Продемонстрировано, что при аллергическом воспалении легких у мышей рекрутирование лимфоцитов и эозинофилов подавляется высокими дозами α-токоферола [5,[17][18][19]35]. Пациенты с бронхиальной астмой, хронической обструктивной болезнью легких, муковисцидозом характеризуются низким уровнем концентрации α-токоферола в сыворотке крови [43,44,48]. Применение α-токоферола с учетом его противовоспалительного и антиоксидантного действия было предложено при лечении больных с бронхиальной астмой, ХОБЛ, муковисцидозом [11,50].…”